Alchemab Therapeutics Ltd.

Time frame: 1 June 2023 - 31 May 2024

Region or country/territory

Sector

Subject or journal group

Article ‘Count’ and ‘Share’ for Alchemab Therapeutics Ltd. based on listed parameters only.

The articles listed below published by authors from Alchemab Therapeutics Ltd., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.

Journal	Count	Share
Nature Immunology	1	0.43

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Latest supplement

Nature Index 2024 AI

The rapid adoption of chatbots such as ChatGPT in mainstream society have placed artificial intelligence (AI) front and centre of the public debate on science in the past two years. Consequently, these tools and other developing AI technologies are raising important questions for the future of research itself. This supplement takes a look at these issues and the latest Nature Index data on the field.

Access free

Nature Strategy Reports

Comprehensive deep-dives and custom high-quality reports into relevant research topics to influence major research and funding decisions.

Learn more

Explore the topics behind the 75,000 papers in the Nature Index 2024 Research Leaders

FREE ACCESS Explore